Citation Impact
Citing Papers
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus
2011
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
2010
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
2014 StandoutNobel
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
2008
Origin and evolution of pathogenic coronaviruses
2018 Standout
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
2020
Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants
2011
M2e-based universal influenza A vaccine
2009
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Unusual biophysics of intrinsically disordered proteins
2012
Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
2019
Treating influenza with statins and other immunomodulatory agents
2013
Drugs to cure avian influenza infection – multiple ways to prevent cell death
2013
A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates
2012
An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19
2020
Hyperimmune IV Immunoglobulin Treatment
2013
COVID-19: A promising cure for the global panic
2020 Standout
Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
2011
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
2013
Tissue-resident macrophages
2013 Standout
Structure of Dengue Virus
2002 Standout
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
2016
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
2018 Standout
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
SARS vaccines: where are we?
2009
The cytokine storm of severe influenza and development of immunomodulatory therapy
2015 Standout
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
2020 Standout
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Host response to influenza virus: protection versus immunopathology
2010
Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression
2011
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
2020
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Innate immune responses to influenza A H5N1: friend or foe?
2009
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
2020 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
2012
Corona virus versus existence of human on the earth: A computational and biophysical approach
2020
Antiviral combinations for severe influenza
2014
Host-directed therapies for bacterial and viral infections
2017
Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
2013
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
2015
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Immunomodulatory therapy for severe influenza
2011
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
2009
AAV Vectors Vaccines Against Infectious Diseases
2014
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
The acute respiratory distress syndrome
2012 Standout
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
2011
SARS-CoV-2 vaccines in development
2020 StandoutNature
Structural basis of receptor recognition by SARS-CoV-2
2020 StandoutNature
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus
2009
Double-slit photoelectron interference in strong-field ionization of the neon dimer
2019 Standout
Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
2013
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
2011
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
Human Parvovirus B19
2002 Standout
Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
2014
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
2014
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
2013
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Disease Tolerance as a Defense Strategy
2012 StandoutScience
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
2018
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
M2e-Based Universal Influenza A Vaccines
2015
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Into the Eye of the Cytokine Storm
2012
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Works of Chris Chan being referenced
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
2008
A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
2010
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
2010
Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
2009
Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
2008
Wild Type and Mutant 2009 Pandemic Influenza A (H1N1) Viruses Cause More Severe Disease and Higher Mortality in Pregnant BALB/c Mice
2010
A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses
2011
Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
2008